|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 12, 4388-4400, December 2002
¶
and
*Cancer Research UK London Research Institute, Clare Hall
Laboratories, South Mimms, Herts, EN6 3LD, United Kingdom, and
Department of Pharmacology and Cancer Biology, Duke
University Medical Center, Durham, North Carolina, 27710-3686
| |
ABSTRACT |
|---|
|
|
|---|
Cyclin-dependent kinase (Cdk)2/cyclin E is imported into nuclei
assembled in Xenopus egg extracts by a pathway that
requires importin-
and -
. Here, we identify a basic
nuclear localization sequence (NLS) in the N-terminus of
Xenopus cyclin E. Mutation of the NLS eliminated nuclear
accumulation of both cyclin E and Cdk2, and such versions of cyclin E
were unable to trigger DNA replication. Addition of a heterologous NLS
from SV40 large T antigen restored both nuclear targeting of
Cdk2/cyclin E and DNA replication. We present evidence indicating that
Cdk2/cyclin E complexes must become highly concentrated within nuclei
to support replication and find that cyclin A can trigger replication
at much lower intranuclear concentrations. We confirmed that depletion of endogenous cyclin E increases the concentration of cyclin B necessary to promote entry into mitosis. In contrast to its inability to promote DNA replication, cyclin E lacking its NLS was able to
cooperate with cyclin B in promoting mitotic entry.
| |
INTRODUCTION |
|---|
|
|
|---|
Cyclin-dependent kinases (Cdks) are vital for the
initiation of both the major events of the eukaryotic cell cycle: the
duplication of the genome in S phase and its segregation to two
daughter cells during mitosis. In animal cells, several families of
Cdks and cyclins have roles in cell cycle control. D-type
cyclins complexed to Cdk4/Cdk6 regulate the decision to divide or
differentiate, Cdk2/cyclin E and Cdk2/cyclin A collaborate to initiate
the events of S phase, and Cdk/cyclin A and Cdk1/cyclin B combine
forces to trigger the wholesale reorganization of cellular components at mitosis (Girard et al., 1991
; Pagano et al.,
1992
; Ohtsubo et al., 1995
; Furuno et al., 1999
;
Hu et al., 2001
; Nigg, 2001
).
Cdk/cyclin complexes are regulated by multiple mechanisms that ensure
that they execute their functions at the correct time (Morgan, 1997
);
ubiquitylation and proteolysis of cyclins A and B are critical for
M-phase exit (Wheatley et al., 1997
; den Elzen and Pines,
2001
; Geley et al., 2001
), whereas defects in cyclin E
proteolysis may be associated with certain cancers (Strohmaier et
al., 2001
). The subcellular localization of Cdk/cyclin complexes is also critical for faithful cell cycle control (Pines and Hunter, 1991
; Hagting et al., 1998
; Toyoshima et al.,
1998
; Pines, 1999
; Alt et al., 2000
; Draviam et
al., 2001
), and some progress has been made in identifying the
mechanisms responsible, in particular those used by Cdk/cyclin
complexes to shuttle between the cytoplasm and nucleus (Yang et
al., 1998
; Hagting et al., 1999
; Moore et al., 1999
; Takizawa et al., 1999
). In this article, we
focus attention on the mechanism and relevance of nuclear localization
for the function of Cdk2/cyclin E in Xenopus egg extracts.
Xenopus egg extracts have proved useful for studying the
functions of Cdk/cyclin complexes in cell cycle control. Extracts exhibit excellent synchrony and faithfully recapitulate both S-phase and M-phase processes in vitro. Moreover, it is possible to manipulate their contents by depletion or addition of proteins. Five reports using
such methods have defined multiple roles of Cdk2/cyclin E in egg
extracts. Cdk2/cyclin E is capable of providing all the Cdk activity
necessary to support a single round of chromosomal DNA replication
(Jackson et al., 1995
; Strausfeld et al., 1996
), plays a role in centrosome duplication (Hinchcliffe et al.,
1999
; Lacey et al., 1999
), and is important for maintaining
conditions permissive for cyclin B to activate Cdk1 and bring about
mitosis (Guadagno and Newport, 1996
). There are limits to the abilities of Cdk2/cyclin E, however, for it is unable to trigger entry into mitosis in the absence of other Cdk/cyclin complexes (Strausfeld et al., 1996
), although a recent article claimed that it
influenced the duration of M phase (D'Angiolella et al.,
2001
).
In egg extracts, as in other systems, Cdk2/cyclin E is strongly
concentrated in nuclei (Hua et al., 1997
). Cdk2/cyclin E is imported into nuclei via the conventional importin-
/
-dependent pathway (Moore et al., 1999
). In this article, we define the
sequences required for Cdk2/cyclin E to accumulate in egg extract
nuclei and demonstrate that the concentration of this complex within nuclei is critical for its ability to support DNA replication. In
contrast, the nuclear localization sequences (NLSs) of cyclin E are not
necessary for Cdk2/cyclin E to lower the threshold concentration of
Cdk1/cyclin B necessary to initiate entry into mitosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Xenopus Egg Extracts and Replication Assays
Interphase egg extracts were prepared as previously described
(Smythe and Newport, 1991
); except where noted, cycloheximide (100 µg/ml) was added to prevent the synthesis of endogenous A-type and
B-type cyclins. Cell cycle progression was monitored by removing 1-µl
samples, mixing them 50:50 with 28% formaldehyde, 250 mM sucrose, and
10 mM HEPES-KOH, pH 8, containing 20 µg/ml Hoechst 33258, and
examining the nuclear/chromatin morphology with a Zeiss Axioskop
fluorescence microscope.
Egg extracts were depleted either by two incubations at 4°C with a
20% volume of Affiprep protein-A beads loaded with preimmune or
anti-cyclin E antibodies (experiments in Figures 2 and 6) or by three
incubations on ice with protein A-Dynabeads (Dynal, Oslo, Norway)
loaded with preimmune or anti-cyclin E antibodies (the manufacturer's
recommendations for bead/extract ratios were followed). Both depletion
protocols removed almost all cyclin E, as judged by
immunoblotting, but the Dynabead depletions caused less
damage to the egg extract and enabled replication assays (see below) to
be performed for shorter periods. For the experiment shown in Figure
5C, Cdk/cyclin complexes were depleted on Suc1p beads as previously
described (Strausfeld et al., 1996
).
Kinase assays were performed in a buffer containing 50 mM sodium
-glycerophosphate, 5 mM NaF, 15 mM MgCl2, 3 mM
dithiothreitol (DTT), 3 mM EDTA, 100 µM ATP, and 0.25 mg/ml Histone
H1 (some assays also contained 0.1 mg/ml GST-Rb). Assays spiked with
0.01 vol of 10 µCi/µl
-[32P]ATP were
incubated for 5 min at room temperature and stopped by addition of
SDS-PAGE loading dye. Proteins were separated by 15% SDS-PAGE, and
incorporation of radioactivity into Histone or GST-Rb was
quantified on a phosphorimager.
A method adapted from Jackson et al. (1995)
was used for
replication assays; extracts were supplemented with 1:200 vol of
-[32P]dCTP (10 µCi/µl), and samples were
removed at the times indicated, diluted 10-fold with Replication Stop
buffer (20 mM Tris-Cl, 20 mM EDTA, 0.5% SDS, pH 8), and flash-frozen
in liquid N2. Subsequently, thawed samples were
mixed with an equal volume of 2 mg/ml Protease K in Replication Stop
buffer, incubated for 2-3 h at 37°C, then loaded onto 1%
TAE-agarose gels. After electrophoresis to separate unincorporated
nucleotides, gels were dried and new DNA synthesis was measured on a
phosphorimager. Data are presented from time points that combine an
easily detectable signal with maximum differentiation between mock and
cyclin E depleted extracts. Typically, this occurred at time points
when DNA synthesis in the mock-depleted extract had reached ~50% of
the final value.
To assay replication at the level of individual nuclei, extracts were also supplemented with 1:100 volumes of 1 mM Oregon Green dUTP (Molecular Probes, Eugene, OR). Nuclei were separated from extracts by diluting samples fivefold in extract buffer (10 mM HEPES-KOH, pH 7.7, 50 mM KCl, 250 mM sucrose, 5 mM MgCl2, 1 mM DTT), underlaying the diluted samples with a cushion of extract buffer containing 0.5 M sucrose, and spinning at 3000 × g at 4°C for 5 min. The extract supernatant and cushion were removed by aspiration, and the nuclear pellet was resuspended in the Hoechst-supplemented fixative described above and pipetted onto slides for microscopy. Images in the green and blue channels were captured with Improvision's OpenLab software and quantified.
The partitioning of cyclins between nuclei and cytoplasm was assessed
by a protocol adapted from that of Walter et al. (1998)
. Interphase extracts prepared in the absence of cycloheximide were supplemented with 10 µM nocadazole and respun at 10,000 × g at 4°C for 10 min, and the straw-colored extract layer
was removed by side puncture. This extract was supplemented with an
energy regeneration system, 3500 sperm heads/µl and 50 µg/ml
aphidicolin, to prevent entry into mitosis (Dasso and Newport, 1990
).
Cyclin synthesis and import into the nuclei assembled around sperm
heads were allowed to proceed for 80 min. An aliquot of the reaction was removed (total sample) before centrifugation at 10,000 × g at 4°C for 4 min was used to bring nuclei to the top of
the tube. Nuclei-enriched and cytosolic aliquots were withdrawn and,
along with the unfractionated aliquot, were boiled in 10 vol of
SDS-PAGE loading dye.
The stability of cyclin E in extracts was determined by adding 1/20
volume of rabbit reticulocyte lysate programmed with pEspB-CycE-his or
pEspB-CycE
NLS-his (see below) to a cycloheximide-supplemented egg
extract containing 1000 sperm heads/µl. Samples were withdrawn either
immediately or after the indicated time and boiled in 10 vol of
SDS-PAGE loading dye before separation on 12.5% gels and autoradiography.
Antibodies
Samples for immunoblotting were separated by
12.5% SDS-PAGE and transferred to nitrocellulose membranes.
Anti-Xenopus cyclin B2 (X121) and anti-Xenopus
cyclin A1 (DH1) monoclonal antibodies were generated by Julian Gannon
and Dolores Harrison, respectively (Cancer Research UK-Clare Hall).
Rabbit polyclonal antibodies raised against the N-terminal 144 amino
acids of Xenopus cyclin E were described by Strausfeld
et al. (1996)
. Cdk2 was detected by use of a monoclonal
antibody directed against the PSTAIRE epitope. Rabbit polyclonal
antibodies against importin-
and importin-
were a kind gift of
Dirk Görlich (University of Heidelberg). Secondary antibodies
(swine anti-rabbit and goat anti-mouse horseradish peroxidase) were
obtained from Dako (Glostrup, Denmark), and signals were detected by
enhanced chemiluminescence.
Plasmids
The original pGEX-cyclin E plasmid encoding the
GST-Xenopus cyclin E fusion protein used in the initial
experiments (Figure 1, A and B) has been
described previously (Moore et al., 1999
). Digestion of
pGEX-cyclin E with NcoI, followed by Klenow treatment and
self-ligation, yielded pGEX-cyclin E-NT, which encodes a GST-cyclin E
(1-60) fusion protein. Digestion of pGEX-cyclin E with
BamHI and NcoI, followed by Klenow treatment and
self-ligation, produced pGEX-cyclin E (60-409), which encodes a
GST-cyclin E (60-409) chimeric protein.
|
New GST-cyclin E encoding plasmids were constructed with the
pGEX-PP-his backbone, a modified version of pGEX-6P-1 (Pharmacia, Uppsala, Sweden), with the addition of sequences encoding a second 3C
protease cleavage site, followed by a 6-his tag for purification 3' to
the XhoI site in the multiple cloning site. pGEX-PP-his was
made by digesting pGEX-6P-1 with EcoRI and NotI
and ligating in a double-stranded linker comprising the annealed oligo
pair 5'-AATTCCCGGGTCGACTCGAGGTACTATTCCAAGGACCTCATCACCATCATCATCATTAAGC-3 and
5'-GGCCGCTTAATGATGATGGTGATGAGGTCCTTGGAATAGTACCTCGAGTCGA-CCCGGG-3'. Proteins encoded by sequences cloned into pGEX-PP-his in the correct reading frame can be purified by sequential affinity chromatography on
glutathione agarose and Ni2+-NTA-agarose.
Sequences encoding an N-terminally myc-tagged cyclin E sequence were
amplified from the template pEspB-CycE (Bartosch, 1999
) by means of PCR
using the oligo pair 5'-CCCGGGGGATCCGATCCTATGGAGCAAAAGCTCATTTCT-3' and
5'-GATGCAGTCCTCGAGGTCTGCTCGATCAGATTTCTG-3', digested with BamHI and XhoI, and ligated to
BamHI/XhoI-cut pGEX-PP-his to yield pGEX-myc-Cyclin E. A variant, pGEX-myc-Cyclin E
NLS, was made by the method of Horton and Pease (1991)
: the
BamHI/NcoI fragment encoding the N-terminal 60 amino acids of cyclin E was replaced with PCR-derived sequences in
which the oligo pair
5'-TGTAGTGTGCGCTCCAGAGCTGCTGCTGCAGATGTGACTATTTTC-3' and
5'-GAAAATAGTCACATCTGCAGCAGCTCTGGAGCGC-ACACTACA-3' had been used
to mutate the nucleotides encoding RSRKRK (residues 24-29 of
Xenopus cyclin E) to those encoding RSRAAA. All PCR-derived constructs were verified by sequencing both strands.
Plasmids to express myc-cyclin E-6-his and the
NLS derivative in
coupled in vitro transcription/translation reactions were also
constructed. pEspB-CycE-his was made by replacing the non 6-his-tagged
cyclin E sequence in pEspB-CycE (released by successive treatment with
HindIII, Klenow enzyme, and BglII) with the
fragment encoding myc-cyclin E-6-his liberated from pGEX6P-myc-Cyclin E by treatment with NotI, Klenow enzyme, and BglII.
pEspB-CycE
NLS-his was made by replacing the
BglII-XhoI fragment encoding wild-type cyclin E
with the corresponding sequence from pGEX-myc-Cyclin E
NLS.
Plasmids encoding MBP-tagged cyclin E and cyclin E
NLS were made by
ligating BamHI/Klenow-treated NotI fragments
encoding the myc-Cyclin E-6-his sequences into
BamHI/Klenow-treated HindIII-cut pMalC2. A
plasmid encoding MBP-tagged cyclin E (60-409) was generated by
digesting pMalC2-cyclin E with BamHI and NcoI
followed by Klenow treatment and self-ligation. pET21d-Cyclin A3
encodes a truncated version of bovine cyclin A (here called cyclin
A
N170, equivalent to residues 171 to the C terminus of human cyclin
A2) linked in frame to a 6-his tag at the C terminus (Brown et
al., 1995
). pET21d-Cdk2 was constructed by Mike Howell and encodes
a C-terminally 6-his-tagged Xenopus Cdk2 protein. pGEX-Cdk2
was constructed by Katsumi Yamashita (backbone pGEX-KG) and encodes a
GST-human Cdk2 fusion protein. pGEX-importin-
and pGEX-importin-
encode chimeric proteins linking GST to Xenopus importin-
and human importin-
, respectively, and have been described
previously (Moore et al., 1999
), as have pGEX-IBB and
pGEX-NLS, which encode controls for the importin binding assays (Rexach
and Blobel, 1995
; Moore et al., 1999
). pGEX-Rb encodes a
chimeric protein comprising GST fused to the pocket domain of the human
retinoblastoma protein (residues 372-928) and has been described
previously (Kaelin et al., 1991
).
Protein Production and Labeling with Fluorescent Tags, Nuclear Import, and Import Factor-Binding Assays
The cyclin B used in this work was purified by chromatography on
Ni2+-NTA agarose as described previously (Kumagai
and Dunphy, 1995
) from Sf9 cells grown at 27°C for 48 h after
infection with a baculovirus encoding a 6-his 4-myc-tagged version of
human Cyclin B1 (Takizawa et al., 1999
). The N-terminal myc
tags make this protein effectively nondegradable in egg extracts (Jin
et al., 1998
). Full-length 6-his-tagged human cyclin A2, as
used in the experiment reported in Figure 5A, was similarly expressed
in Sf9 cells by use of a baculoviral construct provided by David Morgan
(University of California, San Francisco) and purified on
Ni2+-NTA agarose. More generally, protein
production was performed in Escherichia coli BL21 (DE3)
"Codon Plus" cells, inducing cultures grown at room temperature
with IPTG overnight. Shorter inductions at 37°C were possible for
unfused GST and the control proteins for the importin binding assays.
Proteins were purified by affinity chromatography, taking advantage of
the GST, MBP, or 6-his fusion tags in accordance with standard
procedures, and concentrated in Vivaspin ultrafiltration units. It was
necessary to remove aggregates from MBP-cyclin E preparations by
ultracentrifugation (250,000 × g, 30 min, at 2°C). Importin-
and importin-
were liberated from their GST fusion tag
by treatment with thrombin, while the GST moiety was bound to
glutathione-agarose beads. Similarly, the cyclin E proteins used in our
early add-back experiments (Figure 2)
were liberated from their GST fusion tags by treatment with 3C
protease. Uncleaved MBP-cyclin E and GST-Cdk2 were used for subsequent
experiments (Figures 3, 4, 5, and 7),
except that uncleaved GST-cyclin E proteins were used for the work
presented in Figure 6. All proteins were dialyzed against storage
buffer (20 mM HEPES-KOH, pH 7.75, 100 mM KCl, 200 mM sucrose, 2 mM
MgCl2, 1 mM DTT), divided into small aliquots,
and flash-frozen in liquid N2.
|
|
For nuclear import experiments, portions of GST-cyclin E, GST-cyclin
E
NLS, and GST-Cdk2 were labeled with Texas Red maleimide C2
(Molecular Probes) by mixing between 1:1 and 1:5 ratios of protein and
dye in PBS and incubating at room temperature in the dark for 2 h.
Reactions were quenched by addition of 10 mM DTT, and the labeled
proteins were dialyzed against storage buffer. Demembranated sperm
chromatin (1000 nuclei/µl) was added to interphase Xenopus
egg extract. After nuclei had been allowed to assemble for 40-60 min,
~200 nM Texas Red-labeled protein was added and the extracts were
incubated at room temperature for the time indicated. Aliquots were
withdrawn, mixed with Hoechst 33258-containing fixative, placed on
slides, and examined by fluorescence microscopy.
Binding assays using immobilized GST-NLS or GST-Cyclin E proteins and
soluble importins
and
were performed as previously described
(Moore et al., 1999
); the concentration of each importin subunit was 100 µg/ml. For assays using Xenopus egg
extract as a source of Cdk2, extract was diluted 10-fold before
addition to beads. Beads were washed 4 times with PBS plus 10 mg/ml
cas-amino acids plus 0.1% Tween-20 and 2 times in PBS before analysis
by SDS-PAGE and Western blotting. Binding assays using immobilized GST-importin-
and in vitro-translated
35S-labeled cyclin E were performed as previously
described (Moore et al., 1999
).
| |
RESULTS |
|---|
|
|
|---|
Xenopus Cyclin E Contains an N-Terminal Basic NLS That Is Conserved in Many Vertebrate Cyclin E Sequences
We previously showed that Xenopus Cdk2/cyclin E
complexes are imported into egg extract nuclei via the conventional
importin-
/
-dependent pathway (Moore et al., 1999
).
The interaction between the importin heterodimer and the Cdk2/cyclin E
complex occurs via a direct interaction between importin-
and cyclin
E (Moore et al., 1999
). These data suggested that cyclin E
possesses a basic NLS. Xenopus cyclin E contains the
sequence RSRKRK between residues 24 and 29, which is a possible
candidate. Chimeric proteins comprising residues 1-60 or 60-409 of
cyclin E or full-length cyclin E fused to GST were produced in E. coli and purified on glutathione-Sepharose beads. As controls, GST
and two GST-NLS proteins (see MATERIALS AND METHODS) were also
expressed in bacteria.
In solution binding assays, the control proteins exhibited the expected
associations with importin-
and -
. Figure 1A shows that unfused
GST did not bind importins (lane 2), whereas GST-IBB (containing the
importin-
binding sequences from importin-
) associated only with
importin-
(lane 3). GST-NLS (containing the basic NLS from the SV40
large T antigen) beads retained both the
and
subunits of the
importin heterodimer (lane 4), as did full-length GST-cyclin E (lane
5). Figure 1B shows that GST-cyclin E bound Cdk2 from egg extracts.
GST-Cyclin E (60-409) retained the ability to bind Cdk2 but was unable
to associate with importin (lane 7). Conversely, the GST-cyclin E
(1-60) protein was able to bind to importin as efficiently as the
full-length protein (lane 6) but was not associated with Cdk2 (Figure
1A).
The sequence RSRKRK was reminiscent of a validated NLS (sequence
KSRKRKL) in the v-jun protein (Chida and Vogt, 1992
) and is conserved
in all known examples of vertebrate cyclin E1 (see Figure 1C for an
alignment of the N-termini of cyclin E1 from various vertebrate
species). Mutation of the sequence encoding residues 27-29 from KRK to
AAA dramatically reduced the amount of in vitro-translated cyclin E
that was captured on immobilized GST-importin-
(Figure 1D).
Wild-type and
NLS cyclin E (containing the KRK to AAA mutation)
proteins were expressed as GST and MBP fusions in bacteria. The
GST-cyclin E proteins were labeled with Texas red and tested for
nuclear accumulation in frog egg extracts. Although Texas Red-labeled
GST-cyclin E accumulated rapidly in egg extract nuclei, GST-cyclin
E
NLS did not. Even 30 min after addition of labeled protein, little
if any of the fusion protein could be detected in the nuclei (Figure
1E). We also tested the ability of MBP-cyclin E and MBP-cyclin E
NLS
to drive the import of Texas Red-labeled GST-Cdk2 into nuclei (Figure
1F). Because of the lack of free cyclins in egg extracts, Texas Red
GST-Cdk2 remains cytoplasmic if added alone, but the complex with
MBP-cyclin E is rapidly imported into nuclei (significant accumulation
is observed within 3 min). In contrast, MBP-cyclin E
NLS was unable to support the nuclear accumulation of GST-Cdk2 (Figure 1F). These data
indicate that residues 27-29 of Xenopus cyclin E form an essential part of the NLS used by the Cdk2/cyclin E complex in frog egg extracts.
Cdk2/Cyclin E
NLS Complexes Are Unable to Support Chromosomal DNA
Replication
Cyclin E
NLS consistently activated the histone H1 and
GST-Rb kinase activities of Cdk2 to ~80% of the level achieved by
the same concentration of wild-type cyclin E (Figure 2A). The
NLS mutant complex therefore had no major defect in phosphorylating canonical substrates in vitro. Like the wild-type protein, the NLS-mutant cyclin E was very stable in Xenopus egg extracts.
No degradation of 35S-labeled cyclin E or cyclin
E
NLS protein was observed during a 2-h incubation in interphase
extracts containing 1000 nuclei/µl (Figure 2B). To establish how the
cyclin E
NLS mutant performed in more physiological settings, in
particular its ability to promote the onset of S phase, we removed
endogenous Cdk2/cyclin E complexes from extracts of activated
Xenopus eggs by immunodepletion on immobilized anti-cyclin E
antibodies (Figure 2C). As reported previously (Jackson et
al., 1995
; Strausfeld et al., 1996
), this treatment
severely reduced the amount and rate of DNA synthesis observed (see below).
In our first experiments, we permitted nuclei to assemble before adding
back Cdk2/cyclin E complexes, mimicking the situation that would occur
at the G1/S transition in mammalian cells. Sperm heads and
-[32P]dCTP were added to cyclin
E-depleted egg extracts, and nuclear assembly was allowed to proceed
for 40 min. Extracts were then supplemented with 50, 100, or 200 nM
recombinant Cdk2/cyclin E or Cdk2/cyclin E
NLS complexes; the
endogenous concentration of cyclin E is 50-60 nM (Rempel et
al., 1995
). Assays were stopped 90 min after Cdk/cyclin addition,
and DNA synthesis was assessed by agarose gel electrophoresis and
autoradiography (Figure 2D). The wild-type cyclin E complexes
complemented the replication defect in a depleted egg extract in a
dose-dependent manner, but Cdk2/cyclin E
NLS failed to restore
replication. Addition of the nuclear import inhibitor wheat germ
agglutinin (at 1 mg/ml) along with wild-type Cdk2/cyclin E prevented
restoration of replication. These data indicate that Cdk2/cyclin E must
gain access to the nuclear compartment to promote initiation of replication.
In the cell cycles of Xenopus egg extracts, like those of
the early embryo they recapitulate, Cdk2/cyclin E activity is present continuously, its activity oscillating only modestly from a high in
early mitosis to a low in early interphase (Gabrielli et
al., 1992
; D'Angiolella et al., 2001
). Chromatin is
therefore exposed briefly to cytoplasmic Cdk2/cyclin E every time the
nuclei start to assemble after the end of mitosis. We asked whether
Cdk2/cyclin E
NLS could promote replication if it was present during
this window. A range of concentrations of Cdk2/cyclin E or Cdk2/cyclin E
NLS were added back to cyclin E-depleted egg extracts that were incubated for 40 min before addition of demembranated sperm chromatin. Replication was assayed 2 h later. As before, wild-type
Cdk2/cyclin E complexes efficiently complemented the replication defect
of depleted extracts, whereas Cdk2/cyclin E
NLS complexes did not (Figure 2E). Exposure of chromatin to Cdk2/cyclin E before nuclear assembly is therefore not sufficient to trigger DNA replication.
Fusing an NLS to Cdk2 Enables Replication to Be Driven by
Cdk2/Cyclin E
NLS Complexes
The data above do not exclude the possibility that the NLS-like
sequence in cyclin E plays a direct role in substrate recognition as
well as in nuclear targeting for the Cdk2/cyclin E complex. We
therefore asked whether restoring NLS function to Cdk2/cyclin E
NLS
complexes in trans could restore replication competence. A mutant
GST-Cdk2 protein in which the basic NLS from the SV40 large T antigen
(sequence TPPKKKRKVEDPE) (Kalderon et al., 1984
) had been
fused to the C terminus of Cdk2 was expressed in E. coli and
purified. Addition of the T-antigen NLS enabled Texas Red-labeled GST-Cdk2 to accumulate in egg extract nuclei without coaddition of
cyclins (Figure 3A), and complexes containing Cdk2-NLS and cyclin E
were able to phosphorylate histone H1 to the same extent as wild-type
Cdk2/cyclin E (Figure 3B).
We tested the ability of Cdk2-NLS/cyclin E
NLS in the replication
assay. Figure 3C shows that although very little replication was
restored by addition of 100 nM Cdk2/cyclin E
NLS, a similar concentration of Cdk2-NLS/cyclin E
NLS was able to support
considerably more replication, although never to quite the same levels
as the wild-type proteins (Figure 3C). These experiments strongly
suggest that nuclear localization of Cdk2/cyclin E is important for
promoting the onset of DNA replication and that the main role of the
RSRKRK sequence is to promote the entry of cyclin E into the nucleus.
Estimating the Minimum Nuclear Concentration of Cdk2/Cyclin E Required to Support Initiation of Replication
In Xenopus egg extracts supplemented with chromatin,
the 60 nM of Cdk2/cyclin E that is initially distributed throughout an extract becomes concentrated within the assembling nuclei, reaching local levels of perhaps 12 µM (Hua et al., 1997
). The
results presented above show that the complex must have access to
chromatin after nuclear assembly for DNA replication to occur. To test
what concentration of Cdk2/cyclin E within nuclei was necessary to trigger DNA replication, various ratios of cyclin E-depleted and mock-depleted egg extracts were mixed to vary the cyclin E
concentration. In control experiments performed with extracts
supplemented with 35S-labeled cyclin E, the
mock-depletion protocol removed 13% and the anti-cyclin E antibodies
95% of cyclin E. Therefore, we could vary the concentration of cyclin
E over a range between ~3 and 55 nM. Demembranated sperm heads and
-[32P]dCTP were added to the extracts, and
the DNA synthesis that occurred in the first 60 min after sperm
addition was measured (Figure 4A). There
was a roughly linear relationship between the concentration of cyclin E
and the amount of replication. Thus, the full complement of cyclin E is
required for replication to occur at normal rates.
|
Several models can account for this result. First, the reduced nuclear concentrations of Cdk2/cyclin E in depleted egg extracts may slow the rate at which replication origins are fired. Second, the defect might arise from a more general Cdk/cyclin deficit, enabling an opposing activity (e.g., a phosphatase or stoichiometric inhibitor) to block replication. Finally, the limited Cdk2/cyclin E available might be concentrated in a subset of nuclei (for example, in those that assembled most quickly), thereby restricting the maximum amount of replication that could occur.
We first asked whether the replication defect in partially depleted egg
extracts could be restored by the addition of excess Cdk2/cyclin
E
NLS. Buffer or 100 nM Cdk2/cyclin E
NLS was added to either a
mock-depleted extract, a cyclin E-depleted extract, or a mixture (1:4)
of the two, along with demembranated sperm heads and
-[32P]dCTP. Reactions were stopped 45 min
after sperm addition, and DNA synthesis was assayed. Cdk2/cyclin
E
NLS did not stimulate the initial rate of replication in the
mock-depleted extract and only slightly increased replication in the
cyclin E-depleted extracts (Figure 4B). This suggests that it is the
nuclear concentration of Cdk2/cyclin E that determines the rate of
replication. In contrast, Cdk2/cyclin E
NLS was able to overcome a
replication block imposed by adding the physiological Cdk inhibitor
Xic1 to egg extracts (data not shown). The decreased replication
observed when the concentration of cyclin E is reduced is thus unlikely
to arise, because a Cdk inhibitor present in the extracts binds and
inactivates the remaining endogenous Cdk2/cyclin E.
If the limited Cdk2/cyclin E available in partially depleted egg
extracts had become sequestered in a small fraction of nuclei, then we
would anticipate that the nuclei containing cyclin E would replicate
normally, whereas those lacking cyclin E would not replicate at all. To
examine this possibility, we supplemented mock-depleted, cyclin
E-depleted, and a 1:1 mixture of the two extracts, with 10 µM Oregon
Green dUTP,
-[32P]dCTP, and demembranated
sperm heads. DNA synthesis in both the extract as a whole and
individual nuclei was quantified after a 60-min incubation (Figure 4C).
The fraction of nuclei that showed strong Oregon Green fluorescence
(defined as at least 50% of the maximum observed in any nucleus) was
reduced from 28% in the mock-depleted to 7% in the semidepleted
extract. However, >80% of the nuclei in both the mock-depleted and
semidepleted extract showed greater incorporation of Oregon
Green-labeled nucleotide into chromosomal DNA than any nucleus
examined in the cyclin E-depleted egg extract.
It was not possible to establish the proportion of nuclei in partially depleted extracts that contained endogenous cyclin E because of the insensitivity of our anti-cyclin E antibodies. Instead, we examined the localization of added Texas Red-labeled GST-cyclin E (25 nM) by fluorescence microscopy in cyclin E-depleted extracts. Texas Red-labeled cyclin E could be detected in 85% of nuclei (55 of 64; data not shown). Thus, even when Cdk2/cyclin E was present at limiting concentrations, it accumulated and triggered replication in the majority of nuclei. These data suggest that the rate of origin firing in all nuclei is reduced when the levels of cyclin E are reduced.
Together, these data strongly suggest that high nuclear concentrations of Cdk2/cyclin E are required for the efficient initiation of DNA replication. Reducing nuclear Cdk2/cyclin E concentrations fivefold (e.g., from 10 to 2 µM) reduces the initial rate of replication by ~80%. We estimate that 3-6 µM Cdk2/cyclin E within nuclei is needed for replication to proceed at ~50% of the normal rate.
Cdk/Cyclin A Does Not Become Concentrated within Nuclei in Xenopus Egg Extracts
A-type cyclins are able to complement the replication defect
in cyclin E-depleted extracts (Jackson et al., 1995
;
Strausfeld et al., 1996
). Indeed, when Cdk2/cyclin E and
Cdk2/cyclin A complexes purified from baculovirus-infected insect cells
were compared in their abilities to restore replication, cyclin
A-containing complexes were considerably more potent than those
containing cyclin E (Strausfeld et al., 1996
). Does cyclin A
also have to accumulate in the nucleus to promote replication? Somewhat
surprisingly, little information is available on how A-type, or indeed
B-type, cyclins became distributed between the nuclear and cytoplasmic fractions of egg extracts.
To address this question, we compared the ability of MBP-tagged cyclin
E and his-tagged human cyclin A protein to promote the accumulation of
Texas Red-labeled GST-Cdk2 in egg extract nuclei. Cyclin A proved to
be markedly less efficient at targeting GST-Cdk2 to the nucleus than
was MBP-cyclin E, although Figure 5A
shows a slight increase in the amount of GST-Cdk2 localizing to nuclei
in the presence of cyclin A. This was not because of reduced binding of
cyclin A to the Cdk2, because cyclin A strongly activated the histone
H1 kinase activity of the Texas Red-labeled GST-Cdk2 preparation (data
not shown). It is possible that the Texas Red labeling procedure had a
greater inhibitory effect on the import of Cdk2/cyclin A than
Cdk2/cyclin E, because the import pathways appear to be different for
the two cyclins (Jackman et al., 2002
). We therefore tested
whether endogenous newly synthesized cyclin A was imported into nuclei.
We used a protocol for the rapid separation of nuclei from cytosol that
relies on the high buoyancy of nuclei in egg extracts prepared by
low-speed centrifugation (Walter et al., 1998
).
Immunoblots of the cytosolic and nuclear fractions were
probed with antibodies against cyclins E, A1, and B2. Figure 5B shows
that, as expected, cyclin E became highly concentrated within nuclei
after an 80-min incubation. By contrast, the endogenous
Xenopus cyclin A1 did not become highly concentrated within
nuclei; most of the protein remained cytoplasmic, although some was
detected in the nuclear fraction (Figure 5B). As expected from previous
studies in intact oocytes (Gautier and Maller, 1991
), cyclin B2 was
cytoplasmic in egg extracts and was almost entirely excluded from the
nuclear fraction.
|
We next asked whether promoting the nuclear accumulation of cyclin
A-dependent kinase would increase its ability to drive DNA
replication. Endogenous Cdk/cyclin complexes were removed from egg
extracts by depletion on Suc1-Sepharose beads and replaced with either
wild-type or NLS-tagged Cdk2 complexed with cyclin E, cyclin E
NLS,
or cyclin A. Cdk2/cyclin A proved more potent than Cdk2/cyclin E at
triggering DNA replication. In the experiment shown in Figure 5C,
12-25 nM Cdk2/cyclin A restored as much replication as 100-200 nM
Cdk2/cyclin E. As before, Cdk2/cyclin E
NLS was unable to restore
significant amounts of replication, a defect largely overcome by fusing
an NLS to the C-terminus of Cdk2. Cdk2-NLS/cyclin A complexes were no
more effective than Cdk2/cyclin A at driving replication. Nuclear
concentrations of 12-25 nM Cdk2/cyclin A therefore suffice to support
DNA replication at >50% of the normal rate. Thus, if we compare the
intranuclear concentrations required in this system, it seems that
cyclin A is at least 100 times more efficient than cyclin E at
promoting replication.
Cdk2/Cyclin E
NLS Complexes Can Help to Promote Entry into
Mitosis
When cyclin E levels are reduced by immunodepletion of egg
extracts, the resulting preparations require higher levels of cyclin B
than normal to promote nuclear envelope breakdown and chromosome condensation (Guadagno and Newport, 1996
). We wondered whether the
subcellular location of cyclin E was important for this effect. To test
this, we supplemented mock-depleted or cyclin E-depleted interphase
egg extracts with demembranated sperm heads (~1000/µl) to provide a
template for nuclear assembly and 5 mM caffeine to override the S-M
checkpoint pathway (Dasso and Newport, 1990
). Nuclei were allowed to
assemble for 45 min, and then extracts were supplemented with buffer,
100 nM Cdk2/cyclin E, or 100 nM Cdk2/cyclin E
NLS. After an
additional 15 min at room temperature, samples were split between tubes
containing a range of concentrations of recombinant cyclin B1. The
state of the nuclei and of the chromatin in the extracts was examined
by fluorescence microscopy 45 min later.
Figure 6 shows that in mock-depleted
extracts, morphological changes in nuclei consistent with M-phase entry
were produced by 60 nM of the cyclin B1 preparation, but extracts
lacking cyclin E required 120 nM of added cyclin B1. Addition of either
100 nM Cdk2/cyclin E or Cdk2/cyclin E
NLS to the cyclin E-depleted
extracts enabled 60 nM cyclin B1 to provoke entry into mitosis. These
data suggest that Cdk2/cyclin E complex does not have to enter nuclei to collaborate with cyclin B at the interphase to mitosis transition, at least under the conditions of this experiment.
|
If reducing the Cdk2/cyclin E activity delayed the interphase/mitosis
transition, excess Cdk2/cyclin E might accelerate entry into mitosis.
We prepared "cycling" egg extracts that synthesize A- and B-type
cyclins and oscillate between S phase and M phase (Murray, 1991
), added
demembranated sperm, and then after 50 min, supplemented them with
either buffer or 0.6 µM Cdk2/cyclin E. Figure
7 shows that nuclear envelope breakdown
and chromosome condensation were observed at 130 min in the
buffer-supplemented extract, and the onset of these events was advanced
by ~30 min in the extract to which Cdk2/cyclin E had been added.
Addition of Cdk2/cyclin E complexes lacking nuclear localization
signals was not as effective at advancing the timing of entry into
mitosis in these cycling extracts. In the experiment shown in Figure 7, addition of a higher concentration (1 µM) of Cdk2/cyclin E
N60 (a
truncated form of cyclin E lacking the N-terminal 60 residues) accelerated the interphase/mitosis transition by ~20 min (compared with the 30-min acceleration seen with wild-type cyclin E). In other
tests, the acceleration was even less. As recently reported by others
(D'Angiolella et al., 2001
; Tunquist et al.,
2002
), we found that addition of high levels of Cdk2/cyclin E to
cycling egg extracts frequently caused a mitotic arrest and impaired
cyclin B degradation (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
The results in this article clearly establish that the N-terminus
of Xenopus cyclin E contains a basic NLS that is essential for the nuclear accumulation of Cdk2/cyclin E in egg extracts. Removal
of the N-terminus of cyclin E prevents it from interacting with the
importin heterodimer, and mutation of the candidate basic NLS sequence,
the RSRKRK motif, prevents the accumulation of cyclin E within egg
extract nuclei. Although Cdk2/cyclin E
NLS complexes have nearly
wild-type kinase activity, as measured in solution with histone H1 as a
substrate, their ability to support DNA replication is seriously
compromised. This deficiency can be overcome by targeting the mutant
complexes to the nucleus with a heterologous NLS. We also provide
evidence that Cdk2/cyclin E must accumulate to high concentrations in
the nucleus to trigger DNA replication. Nuclear accumulation, however,
is not necessary for Cdk2/cyclin E to perform all its functions, as
revealed by the similar threshold level of cyclin B required to trigger
entry into mitosis when wild-type cyclin E is replaced by Cdk2/cyclin
E
NLS.
The Role of Cdk2/Cyclin E at the Interphase/Mitosis Transition
Guadagno and Newport (1996)
showed that either addition of
the p21 Cdk inhibitor or depletion of cyclin E impaired the ability of
interphase Xenopus egg extracts to enter mitosis in response to added recombinant cyclin B. These results were interpreted to
indicate that Cdk2/cyclin E, in addition to its roles during S phase,
also operates at the interphase/mitosis transition in Xenopus eggs. We have confirmed these results. In the
absence of cyclin E, the minimum concentration of cyclin B1 required to trigger mitosis was doubled from 60 to 120 nM. The magnitude of this
difference is smaller than reported by Guadagno and Newport (1996)
, but
they reported results from only a limited range of cyclin B
concentrations. We find that both wild-type Cdk2/cyclin E and
Cdk2/cyclin E
NLS are able to restore the 60-nM threshold level of
cyclin B to trigger Cdk1/cyclin B activation, but we also have evidence
that nuclear Cdk2/cyclin E is somewhat more potent at assisting cyclin
B to initiate mitosis (see below).
We found that artificially elevated Cdk2/cyclin E activity in
Xenopus egg extracts tended to accelerate entry into mitosis in egg extracts allowed to synthesize their own cyclin B, although no
amount of added cyclin E could evoke any M-phase events if added to
cycloheximide-supplemented extracts (data not shown). The Cdk2/cyclin E
concentration must be increased by ~10-fold to see significant
acceleration of nuclear envelope breakdown, but the protein does not
need to be concentrated in the nucleus for this effect. As little as 1 µM of nonnuclear Cdk2/cyclin E can therefore deregulate entry into
mitosis, which, as discussed below, is substantially less than the
concentration of nuclear Cdk2/cyclin E required to efficiently perform
its normal function in S phase. Although nonnuclear Cdk2/cyclin E can
accelerate entry into mitosis, we found that wild-type cyclin E was
more potent. In this regard, it is interesting that structures to which
Cdk2/cyclin E has been reported to localize, namely, the nucleus (Hua
et al., 1997
) and centrosomes (Hinchcliffe et
al., 1999
), are required for the normal kinetics of activation of
Cdk1/cyclin B in fertilized Xenopus eggs (Perez-Mongiovi
et al., 2000
). Currently, it is unclear what substrates
Cdk2/cyclin E must phosphorylate to promote entry into mitosis
transition, but as discussed by Guadagno and Newport (1996)
, Cdc25C
would be an obvious candidate, for it is known that Cdk2/cyclin E can
phosphorylate sites in the regulatory domain of Cdc25C leading to
activation of its phosphatase activity (Izumi and Maller, 1995
).
In mammalian somatic cells, Cdk2/cyclin A is thought to regulate the
timing of activation of Cdk1/cyclin B (Pagano et al., 1992
;
Furuno et al., 1999
), but unlike the situation in
Xenopus extracts, there is no evidence that Cdk2/cyclin E
can perform a similar function. Indeed, high concentrations of
Cdk2/cyclin E (2-4 µM) failed to accelerate entry into mitosis when
microinjected into HeLa cells in G2, whereas high levels of Cdk2/cyclin
A did advance entry into mitosis (Furuno et al., 1999
).
Thus, there seems to be a difference in the response of the frog egg
extracts and mammalian cells to elevated cyclin E.
To Trigger DNA Replication, Cdk2/Cyclin E Must Be Concentrated within Nuclei
It is hardly surprising that Cdk2/cyclin E requires access to
chromatin after nuclear assembly to promote DNA replication. We were
more surprised to find that Cdk2/cyclin E must be concentrated to high
levels within nuclei to trigger the onset of DNA replication. Even
modest reductions in the concentration of Cdk2/cyclin E in Xenopus egg extracts led to a substantial defect in DNA
replication compared with normal controls. The inhibition was not
corrected by adding back Cdk2/cyclin E
NLS, which does not accumulate
in nuclei. For replication to occur at maximum rates, therefore, it
seems that Cdk2/cyclin E must be concentrated to surprisingly high
levels within nuclei, perhaps 6-10 µM. This is somewhat surprising, given that 100 nM of NLS-deficient Cdk2/cyclin E suffices to play a
supporting role at entry into mitosis and that 1 µM can substantially advance its normal onset. Why is this high concentration required?
In a widely accepted "two-step" model for replication initiation,
the assembly of prereplicative complexes at origins of replication is
separated in time from origin firing (Diffley, 1996
). Activation of S
phase promoting Cdk/cyclin complexes has the dual role of firing
replication initiation from prereplicative complexes and preventing the
formation of new complexes (Dahmann et al., 1995
). Assembling functional prereplicative complexes therefore requires a
period of low Cdk activity after mitosis. In most systems, this is
achieved by inactivation of CDKs by degradation of cyclins during
mitotic exit. In Xenopus egg extracts, however, cyclin E is
a stable protein, and Cdk2/cyclin E activity is present throughout the
cell cycle, oscillating only over a narrow range between interphase and
mitosis (Gabrielli et al., 1992
; Rempel et al.,
1995
).
In the absence of other regulatory mechanisms, the stability of cyclin
E in early frog embryos would seem to pose a problem for the
"two-step" model. Could it be that the concentration of cyclin E
within the nucleus provides a way to vary the activity of cyclin
E-associated kinase with respect to its chromatin-associated targets?
According to this view, high concentrations of Cdk2/cyclin E activity
are necessary to trigger replication, because the initiation machinery
has evolved so that total concentration of active Cdk2/cyclin E present
in the cells at the end of mitosis does not impair assembly of
prereplicative complexes. In fact, the replication machinery is quite
resistant to increased Cdk2/cyclin E activity during nuclear assembly.
To inhibit replication by even 30-50% requires the addition of 1-1.5
µM of either wild-type or cytoplasmically targeted Cdk2/cyclin E
(data not shown) (Hua et al., 1997
).
Cdk/Cyclin A Does Not Need to Be Concentrated within Nuclei to Trigger DNA Replication
Unlike cyclin E, cyclin A levels oscillate in the early cell
cycles of fertilized frog eggs (Minshull et al., 1990
).
Oscillations of Cdk/cyclin A activity with respect to chromatin will
therefore occur during cell cycle progression, even without cyclin A
becoming concentrated in the nuclei. Nevertheless, we were surprised to find that cyclin A did not become significantly concentrated within nuclei assembled in egg extracts. This differs from the situation in
vertebrate somatic cells, in which the steady-state localization of
cyclin A is nuclear but the time scales involved are different. The
nuclear import of cyclin A, at least in Xenopus oocytes, is considerably slower than that of cyclin E (Moore et al.,
1999
). We should emphasize, however, that some cyclin A can be detected in the nuclear fraction of egg extracts. It appears that these low
nuclear concentrations (12-25 nM) of Cdk2/cyclin A are able to support
replication at near normal rates in extracts from which the endogenous
Cdk-complement has been depleted. This implies that Cdk2/cyclin A is
perhaps 200- to 400-fold more effective at supporting DNA replication
than Cdk2/cyclin E.
Why is cyclin A so much better at promoting replication than cyclin E? Consistent with other reports, we find that the specific activity of Cdk2/cyclin A is approximately eightfold higher than Cdk2/cyclin E with histone H1 as a substrate (data not shown). Although this difference in activity is in the right direction, it cannot explain the massive differences in efficiency with which the two enzymes promote DNA replication. It is possible that the relevant substrate is far more effectively phosphorylated by Cdk2/cyclin A than by Cdk2/cyclin E. Alternatively, high local concentrations of Cdk2/cyclin A with respect to this substrate may be achieved by other means, such as a strong interaction between cyclin A and its (hypothetical) chromatin-bound receptor. It will be necessary to identify the critical substrates phosphorylated by Cdk/cyclin complexes to trigger DNA replication to reach definitive conclusions.
The situation in Xenopus egg extracts, in which
replication can apparently be driven by either cyclin E- or cyclin
A-dependent kinases, is unusual. In cultured mammalian cells, both
appear to be required (Pagano et al., 1992
; Ohtsubo et
al., 1995
). Studies in intact mammalian cells have always been
complicated by the involvement of the S phase promoting Cdk2/cyclin
complexes in the transcription of mRNAs for proteins required for
replication. One recent report, however, used an in vitro system based
on G1 nuclei and cytoplasm from mammalian cells,
supplemented with relevant recombinant proteins, to probe the functions
of the two cyclin-dependent kinases. It was proposed that at least
during the transition into S phase from the G1
phase block imposed by serum withdrawal, cyclin E- and cyclin
A-dependent kinases execute sequential and separate functions
(Coverley et al., 2002
). According to these authors, cyclin
E "opens a window of opportunity" for replication complex assembly,
which is then closed by the activation of cyclin A. Further increases
of Cdk2/cyclin A activity are then proposed to fire replication
origins. In this system, Cdk2/cyclin E seems to be unable to trigger
replication itself (Coverley et al., 2002
). In contrast,
cyclin E is normally essential for DNA replication in
Drosophila embryos, and cyclin A is not required. However, cyclin A can complement for an absence of cyclin E if constraints on
Cdk/cyclin A activity are overcome (Knoblich et al., 1994
; Sprenger et al., 1997
). Explaining these differences between
different organisms at different stages of development really requires, as we said above, identification of the salient substrates and a more
detailed understanding of the pathways for assembly and firing of the
origins of DNA replication.
Nucleocytoplasmic Transport of Cdk2/Cyclin E in Somatic Cells
The sequence responsible for the uptake of cyclin E into
nuclei in egg extracts is conserved in other vertebrate cyclin E proteins. Surprisingly, several lines of evidence suggest that these
motifs are not required for the nuclear localization of Cdk2/cyclin E
in mammalian somatic cells. Thus, Kelly et al. (1998)
found
that mutation of the RSRKRK motif of human cyclin E to RSRAAA neither
prevented the nuclear accumulation of the protein nor its ability to
accelerate S-phase onset in transiently transfected murine cells. In
fact, even deletion of the entire N-terminus did not stop the nuclear
accumulation of human cyclin E (Porter et al., 2001
).
Redundant mechanisms for cyclin E nuclear uptake therefore seem to
exist in somatic cells, and these mechanisms may be quite efficient:
the N-terminally truncated cyclin E protein was reported to remain
exclusively nuclear (Porter et al., 2001
).
The localization of Cdk2/cyclin E in somatic cells may be subject
to additional levels of control that are, as far as we know, absent in
Xenopus egg extracts. For example, Keenan et al.
(2001)
report that PD98059, an inhibitor of the mitogen-activated
protein (MAP) kinase kinase, MEK, prevents Cdk2/cyclin E nuclear
localization in human cells. Because cyclin E and importin-
proteins
purified from bacteria are able to associate without incubation in egg extracts, we can exclude the possibility that the phosphorylation of
either protein by members of the MAP kinase family is required for
their interaction. It is possible that Cdk2/cyclin E complexes shuttle
in and out of somatic cell nuclei (Jackman et al., 2002
), and perhaps MAP kinase activity is necessary to downregulate the export
arm of this shuttling. It would be interesting to identify the
pathway(s) of cyclin E localization in somatic cells and how they
contribute to the biological function of the protein.
| |
ACKNOWLEDGMENTS |
|---|
We thank Drs. Birke Bartosch, Michael Rexach, Dirk Görlich, Akiko Kumagai, Bill Dunphy, and David Morgan for generous gifts of reagents. We thank John Diffley and members of the Hunt laboratory for helpful and interesting discussions during the course of this work. We thank Hiro Mahbubani and Jane Kirk for care of the frogs. J.D.M. was supported by fellowships from the Leukemia Research Foundation (Evanston, IL) and from the former Imperial Cancer Research Fund (now Cancer Research UK). S.K. is a scholar of the Leukemia and Lymphoma Society and was supported by National Institutes of Health grant R01 GM60500.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
tim.hunt{at}cancer.org.uk.
¶ Present address: Ribotargets Ltd., Granta Park, Cambridge, CB1 6GB, England.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-07-0449. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-07-0449.
| |
REFERENCES |
|---|
|
|
|---|